---
title: "GLOBAL BIO-CHEM announced its interim results, with a net loss of HKD 155 million, a year-on-year narrowing of 1.91%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255179461.md"
description: "According to the Zhitong Finance APP, GLOBAL BIO-CHEM released its interim results for the six months ending June 30, 2025, with group revenue of HKD 1.186 billion, a year-on-year increase of 31.99%; a net loss of HKD 155 million, a year-on-year narrowing of 1.91%; and a loss per share of HKD 0.017"
datetime: "2025-08-29T10:49:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255179461.md)
  - [en](https://longbridge.com/en/news/255179461.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255179461.md)
---

# GLOBAL BIO-CHEM announced its interim results, with a net loss of HKD 155 million, a year-on-year narrowing of 1.91%

According to the Zhitong Finance APP, GLOBAL BIO-CHEM (00809) announced its interim results for the six months ending June 30, 2025, with group revenue of HKD 1.186 billion, a year-on-year increase of 31.99%; a net loss of HKD 155 million, a year-on-year narrowing of 1.91%; and a loss per share of HKD 0.017

### Related Stocks

- [00809.HK](https://longbridge.com/en/quote/00809.HK.md)

## Related News & Research

- [Krugman on Hassett economic growth projections: ‘We haven’t had that in generations’](https://longbridge.com/en/news/282391603.md)
- [PegBio Wins China Nod for Hong Kong Share Full Circulation](https://longbridge.com/en/news/282277506.md)
- [China's March soybean imports rise 14.9% from a year ago](https://longbridge.com/en/news/282622541.md)
- [Alstom ADR (OTCMKTS:ALSMY) Short Interest Update](https://longbridge.com/en/news/282438036.md)
- [Genscript Biotech Sets 2026 AGM to Approve Accounts, Board Mandates and Share Issuance Authority](https://longbridge.com/en/news/282529201.md)